Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

about

Harms from medicines: inevitable, in error or intentional.Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Drugs for rare disorders.

P2860

Q37635191-F495E3BA-197F-496F-B39E-ED53A6B8C354 Q38753644-DC9E6746-F572-41B4-B946-0FA53B91FEEC Q47334709-1C83EE7B-DC78-4C9A-B42E-9AA43BEAC11A

P2860

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

Item

http://www.wikidata.org/entity/Q53353947

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@en

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@nl

type

Item

label

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@en

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@nl

prefLabel

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@en

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@nl

P1476

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

@en

P2093

Ana Alfirevic

http://www.w3.org/2001/XMLSchema#string

B Kevin Park

http://www.w3.org/2001/XMLSchema#string

Dean J Naisbitt

http://www.w3.org/2001/XMLSchema#string

P2860

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.

Avidity determines T-cell reactivity in abacavir hypersensitivity.

Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.

Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.

P304

1567-1569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.12.146

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Munir Pirmohamed

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23148633

http://www.w3.org/2001/XMLSchema#string

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

about

P2860

P2860

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698